Found: 328
Select item for more details and to access through your institution.
Type 1 Myocardial Infarction in Patients With Acute Ischemic Stroke.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 7, p. 703, doi. 10.1001/jamaneurol.2024.1552
- By:
- Publication type:
- Article
Cardiometabolic and immune response to exercise training in patients with metabolic syndrome: retrospective analysis of two randomized clinical trials.
- Published in:
- Frontiers in Cardiovascular Medicine, 2024, p. 1, doi. 10.3389/fcvm.2024.1329633
- By:
- Publication type:
- Article
Impairment of the adrenergic reserve associated with exercise intolerance in a murine model of heart failure with preserved ejection fraction.
- Published in:
- Acta Physiologica, 2024, v. 240, n. 4, p. 1, doi. 10.1111/apha.14124
- By:
- Publication type:
- Article
Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial.
- Published in:
- ESC Heart Failure, 2024, v. 11, n. 1, p. 209, doi. 10.1002/ehf2.14465
- By:
- Publication type:
- Article
Supervised exercise training in patients with advanced heart failure and left ventricular assist device: A multicentre randomized controlled trial (Ex‐VAD trial).
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 12, p. 2252, doi. 10.1002/ejhf.3032
- By:
- Publication type:
- Article
Initial therapeutic anticoagulation with rivaroxaban compared to prophylactic therapy with heparins in moderate to severe COVID-19: results of the COVID-PREVENT randomized controlled trial.
- Published in:
- Clinical Research in Cardiology, 2023, v. 112, n. 11, p. 1620, doi. 10.1007/s00392-023-02240-1
- By:
- Publication type:
- Article
Pitfalls of mitral regurgitation assessment in the presence of mitral valve prolapse.
- Published in:
- Echocardiography, 2023, v. 40, n. 8, p. 862, doi. 10.1111/echo.15583
- By:
- Publication type:
- Article
Reply to 'Vericiguat in heart failure with reduced ejection fraction: the right choice above all else? The answer may lie in time'.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1470, doi. 10.1002/ejhf.2964
- By:
- Publication type:
- Article
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 7, p. 936, doi. 10.1002/ejhf.2894
- By:
- Publication type:
- Article
Biventricular cardiac power reserve in heart failure with preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 7, p. 956, doi. 10.1002/ejhf.2867
- By:
- Publication type:
- Article
Effect of vericiguat on left ventricular structure and function in patients with heart failure with reduced ejection fraction: The VICTORIA echocardiographic substudy.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 7, p. 1012, doi. 10.1002/ejhf.2836
- By:
- Publication type:
- Article
Acute Infections and Inflammatory Biomarkers in Patients with Acute Pulmonary Embolism.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 10, p. 3546, doi. 10.3390/jcm12103546
- By:
- Publication type:
- Article
Mechanistic assessment and ablation of left ventricular assist device related ventricular tachycardia in patients with severe heart failure.
- Published in:
- Frontiers in Physiology, 2023, v. 14, p. 1, doi. 10.3389/fphys.2023.1086730
- By:
- Publication type:
- Article
German Cardiac Arrest Registry: rationale and design of G-CAR.
- Published in:
- Clinical Research in Cardiology, 2023, v. 112, n. 4, p. 455, doi. 10.1007/s00392-022-02044-9
- By:
- Publication type:
- Article
G q -Mediated Arrhythmogenic Signaling Promotes Atrial Fibrillation.
- Published in:
- Biomedicines, 2023, v. 11, n. 2, p. 526, doi. 10.3390/biomedicines11020526
- By:
- Publication type:
- Article
The marantic kiss: potential novel pathognomonic echocardiographic sign of non-bacterial thrombotic endocarditis.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2023, v. 24, n. 1, p. e19, doi. 10.1093/ehjci/jeac196
- By:
- Publication type:
- Article
Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 1, p. 108, doi. 10.1002/ejhf.2726
- By:
- Publication type:
- Article
Vericiguat and NT‐proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial.
- Published in:
- ESC Heart Failure, 2022, v. 9, n. 6, p. 3791, doi. 10.1002/ehf2.14050
- By:
- Publication type:
- Article
Nitric oxide metabolites: associations with cardiovascular biomarkers and clinical parameters in patients with HFpEF.
- Published in:
- ESC Heart Failure, 2022, v. 9, n. 6, p. 3961, doi. 10.1002/ehf2.14116
- By:
- Publication type:
- Article
Evaluation of the HFA‐PEFF Score: results from the prospective DIAST‐CHF cohort.
- Published in:
- ESC Heart Failure, 2022, v. 9, n. 6, p. 4120, doi. 10.1002/ehf2.14131
- By:
- Publication type:
- Article
Dyskalemia in people at increased risk for heart failure: findings from the heart 'OMics' in AGEing (HOMAGE) trial.
- Published in:
- ESC Heart Failure, 2022, v. 9, n. 6, p. 4352, doi. 10.1002/ehf2.14086
- By:
- Publication type:
- Article
Impact of different training modalities on high‐density lipoprotein function in HFpEF patients: a substudy of the OptimEx trial.
- Published in:
- ESC Heart Failure, 2022, v. 9, n. 5, p. 3019, doi. 10.1002/ehf2.14032
- By:
- Publication type:
- Article
The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 9, p. 1559, doi. 10.1002/ejhf.2579
- By:
- Publication type:
- Article
Efficacy and safety of vericiguat in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan: insights from the VICTORIA trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
CMR findings after COVID-19 and after COVID-19-vaccination—same but different?
- Published in:
- International Journal of Cardiovascular Imaging, 2022, v. 38, n. 9, p. 2057, doi. 10.1007/s10554-022-02623-x
- By:
- Publication type:
- Article
Periostin Augments Vascular Smooth Muscle Cell Calcification via β-Catenin Signaling.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 8, p. 1157, doi. 10.3390/biom12081157
- By:
- Publication type:
- Article
Exercise testing in heart failure with preserved ejection fraction: an appraisal through diagnosis, pathophysiology and therapy - A clinical consensus statement of the Heart Failure Association and European Association of Preventive Cardiology of the European Society of Cardiology.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Light at the end of the tunnel?: Diagnostic and therapeutic strategies for heart failure with preserved ejection fraction.
- Published in:
- Herz, 2022, v. 47, n. 4, p. 291, doi. 10.1007/s00059-022-05125-7
- By:
- Publication type:
- Article
Feasibility and safety of high-power ablation of atrial fibrillation with contact force-sensing catheter: The lesion size index-guided ablation.
- Published in:
- Advances in Clinical & Experimental Medicine, 2022, v. 31, n. 7, p. 715, doi. 10.17219/acem/146917
- By:
- Publication type:
- Article
The non-invasive assessment of myocardial work by pressure-strain analysis: clinical applications.
- Published in:
- Heart Failure Reviews, 2022, v. 27, n. 4, p. 1261, doi. 10.1007/s10741-021-10119-4
- By:
- Publication type:
- Article
Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 771, doi. 10.1002/ejhf.2455
- By:
- Publication type:
- Article
Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 782, doi. 10.1002/ejhf.2468
- By:
- Publication type:
- Article
Effects of sacubitril/valsartan versus valsartan on renal function in patients with and without diabetes and heart failure with preserved ejection fraction: insights from PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 794, doi. 10.1002/ejhf.2450
- By:
- Publication type:
- Article
Left atrial strain predicts exercise capacity in heart failure independently of left ventricular ejection fraction.
- Published in:
- ESC Heart Failure, 2022, v. 9, n. 2, p. 842, doi. 10.1002/ehf2.13788
- By:
- Publication type:
- Article
Update zur diastolischen Herzinsuffizienz.
- Published in:
- MMW: Fortschritte der Medizin, 2022, v. 164, n. 6, p. 45, doi. 10.1007/s15006-022-0835-x
- By:
- Publication type:
- Article
Diabetes and pre‐diabetes in patients with heart failure and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 497, doi. 10.1002/ejhf.2403
- By:
- Publication type:
- Article
Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 497, doi. 10.1002/ejhf.2403
- By:
- Publication type:
- Article
Iron Deficiency Impacts Diastolic Function, Aerobic Exercise Capacity, and Patient Phenotyping in Heart Failure With Preserved Ejection Fraction: A Subanalysis of the OptimEx-Clin Study.
- Published in:
- Frontiers in Physiology, 2022, v. 13, p. 1, doi. 10.3389/fphys.2021.757268
- By:
- Publication type:
- Article
NT‐proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials.
- Published in:
- ESC Heart Failure, 2022, v. 9, n. 1, p. 100, doi. 10.1002/ehf2.13703
- By:
- Publication type:
- Article
Long‐term prognostic value of vasodilator stress cardiac magnetic resonance in patients with atrial fibrillation.
- Published in:
- ESC Heart Failure, 2022, v. 9, n. 1, p. 110, doi. 10.1002/ehf2.13736
- By:
- Publication type:
- Article
Biomarker‐based assessment of collagen cross‐linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 2, p. 321, doi. 10.1002/ejhf.2394
- By:
- Publication type:
- Article
Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial.
- Published in:
- European Journal of Heart Failure. Supplements, 2022, v. 24, n. 2, p. 321, doi. 10.1002/ejhf.2394
- By:
- Publication type:
- Article
Traveling Volunteers: A Multi‐Vendor, Multi‐Center Study on Reproducibility and Comparability of 4D Flow Derived Aortic Hemodynamics in Cardiovascular Magnetic Resonance.
- Published in:
- Journal of Magnetic Resonance Imaging, 2022, v. 55, n. 1, p. 211, doi. 10.1002/jmri.27804
- By:
- Publication type:
- Article
Floppy interatrial septum mimicking an ASD: The role of left atrial pressure.
- Published in:
- Health Science Reports, 2021, v. 4, n. 4, p. 1, doi. 10.1002/hsr2.415
- By:
- Publication type:
- Article
Increased β-adrenergic stimulation augments vascular smooth muscle cell calcification via PKA/CREB signalling.
- Published in:
- Pflügers Archiv: European Journal of Physiology, 2021, v. 473, n. 12, p. 1899, doi. 10.1007/s00424-021-02621-3
- By:
- Publication type:
- Article
NR3C2 genotype is associated with response to spironolactone in diastolic heart failure patients from the Aldo‐DHF trial.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 12, p. 978, doi. 10.1002/phar.2626
- By:
- Publication type:
- Article
Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2021, v. 326, n. 19, p. 1919, doi. 10.1001/jama.2021.18463
- By:
- Publication type:
- Article
Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Zinc Ameliorates the Osteogenic Effects of High Glucose in Vascular Smooth Muscle Cells.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 11, p. 3083, doi. 10.3390/cells10113083
- By:
- Publication type:
- Article
Population Pharmacokinetics and Pharmacodynamics of Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 11, p. 1407, doi. 10.1007/s40262-021-01024-y
- By:
- Publication type:
- Article